Oxford BioMedica

Three blocks displaying from left to right a person a handshake and another person
Manufacturing

OXB expands BMS partnership for CAR-T lentiviral vectors

OXB, a U.K. CDMO, expanded its ongoing partnership with Bristol Myers Squibb to supply lentiviral vectors for the pharma giant’s CAR-T programs.
Joseph Keenan Feb 4, 2026 10:25am
Empty boardroom

OXB purchases N.C. viral vector plant from Resilience for $4.5M

Oct 7, 2025 10:55am
Hand passing wad of bills to other hand

CDMO OXB raises £60M to support US expansion ambitions

Aug 15, 2025 11:30am
Mergers Acquisitions

Oxford Biomedica pays €15M to acquire French CDMO ABL Europe

Dec 5, 2023 9:12am
acquisitions

Korea's SK, England's Oxford Biomedica make M&A moves

Sep 20, 2023 3:25pm
Rentschler Biopharma

Rentschler and Oxford are the latest companies swapping out CEOs

Nov 22, 2022 9:00am